Helle Bogetofte

Helle Bogetofte

Auto-generated profile, based on publicly available information

Helle Bogetofte

Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Stem Cell Reports
Verified
Journal Article
Open access
HFHugo JR Fernandes
Hugo JR Fernandes
EHElizabeth M. Hartfield
Elizabeth M. Hartfield
HCH Christian
H Christian
EEEvangelia Emmanoulidou
Evangelia Emmanoulidou
YZYing Zheng
Ying Zheng
RWRichard Wade-Martins
Richard Wade-Martins
Heterozygous mutations in the glucocerebrosidase gene (GBA) represent the strongest common genetic risk factor for Parkinson's disease (PD), the second most common neurodegenerative disorder. However, the molecular mechanisms underlying this association are still poorly understood. Here, we have analyzed ten independent induced pluripotent stem cell (iPSC) lines from three controls and three unrelated PD patients heterozygous for the GBA-N370S mutation, and identified relevant disease mechanisms. After differentiation into dopaminergic neurons, we observed misprocessing of mutant glucocerebrosidase protein in the ER, associated with activation of ER stress and abnormal cellular lipid profiles. Furthermore, we observed autophagic perturbations and an enlargement of the lysosomal compartment specifically in dopamine neurons. Finally, we found increased extracellular α-synuclein in patient-derived neuronal culture medium, which was not associated with exosomes. Overall, ER stress, autophagic/lysosomal perturbations, and elevated extracellular α-synuclein likely represent critical early cellular phenotypes of PD, which might offer multiple therapeutic targets.

1 August 2013 in Stem Cells
Verified
Journal Article
Closed access
PDF file
MSMaria Sundberg
Maria Sundberg
HBHelle Bogetofte
Helle Bogetofte
TLTristan Lawson
Tristan Lawson
JJJohan Jansson
Johan Jansson
GSGaynor Smith
Gaynor Smith
OIOle Isacson
Ole Isacson

5 July 2019 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
HBHelle Bogetofte
Helle Bogetofte
PJPia Jensen
Pia Jensen
MRMatias Ryding
Matias Ryding
SSSissel I. Schmidt
Sissel I. Schmidt
JOJustyna Okarmus
Justyna Okarmus
Morten MeyerMorten Meyer
Morten Meyer
The protein parkin, encoded by the PARK2 gene, is vital for mitochondrial homeostasis, and although it has been implicated in Parkinson’s disease (PD), the disease mechanisms remain unclear. We have applied mass spectrometry-based proteomics to investigate the effects of parkin dysfunction on the mitochondrial proteome in human isogenic induced pluripotent stem cell-derived neurons with and without PARK2 knockout (KO). The proteomic analysis quantified nearly 60% of all mitochondrial proteins, 119 of which were dysregulated in neurons with PARK2 KO. The protein changes indicated disturbances in oxidative stress defense, mitochondrial respiration and morphology, cell cycle control, and cell viability. Structural and functional analyses revealed an increase in mitochondrial area and the presence of elongated mitochondria as well as impaired glycolysis and lactate-supported respiration, leading to an impaired cell survival in PARK2 KO neurons. This adds valuable insight into the effect of parkin dysfunction in human neurons and provides knowledge of disease-related pathways that can potentially be targeted for therapeutic intervention.

2 March 2023 in Cell Reports
Verified
Journal Article
Open access
HBHelle Bogetofte
Helle Bogetofte
BRBrent J. Ryan
Brent J. Ryan
PJPia Jensen
Pia Jensen
SSSissel I. Schmidt
Sissel I. Schmidt
DVDana L.E. Vergoossen
Dana L.E. Vergoossen
RWRichard Wade-Martins
Richard Wade-Martins
Variants at the GBA locus, encoding glucocerebrosidase, are the strongest common genetic risk factor for Parkinson's disease (PD). To understand GBA-related disease mechanisms, we use a multi-part-enrichment proteomics and post-translational modification (PTM) workflow, identifying large numbers of dysregulated proteins and PTMs in heterozygous GBA-N370S PD patient induced pluripotent stem cell (iPSC) dopamine neurons. Alterations in glycosylation status show disturbances in the autophagy-lysosomal pathway, which concur with upstream perturbations in mammalian target of rapamycin (mTOR) activation in GBA-PD neurons. Several native and modified proteins encoded by PD-associated genes are dysregulated in GBA-PD neurons. Integrated pathway analysis reveals impaired neuritogenesis in GBA-PD neurons and identify tau as a key pathway mediator. Functional assays confirm neurite outgrowth deficits and identify impaired mitochondrial movement in GBA-PD neurons. Furthermore, pharmacological rescue of glucocerebrosidase activity in GBA-PD neurons improves the neurite outgrowth deficit. Overall, this study demonstrates the potential of PTMomics to elucidate neurodegeneration-associated pathways and potential drug targets in complex disease models.

24 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JOJustyna Okarmus
Justyna Okarmus
HBHelle Bogetofte
Helle Bogetofte
SSSissel Ida Schmidt
Sissel Ida Schmidt
MRMatias Ryding
Matias Ryding
SGSilvia García-López
Silvia García-López
Morten MeyerMorten Meyer
Morten Meyer
Mutations in the PARK2 gene encoding parkin, an E3 ubiquitin ligase, are associated with autosomal recessive early-onset Parkinson’s disease (PD). While parkin has been implicated in the regulation of mitophagy and proteasomal degradation, the precise mechanism leading to neurodegeneration in both sporadic and familial PD upon parkin loss-of-function remains unknown. Cultures of isogenic induced pluripotent stem cell (iPSC) lines with and without PARK2 knockout (KO) enable mechanistic studies of the effect of parkin deficiency in human dopaminergic neurons. We used such cells to investigate the impact of PARK2 KO on the lysosomal compartment and found a clear link between parkin deficiency and lysosomal alterations. PARK2 KO neurons exhibited a perturbed lysosomal morphology with enlarged electron-lucent lysosomes and an increased lysosomal content, which was exacerbated by mitochondrial stress and could be ameliorated by antioxidant treatment. We also found decreased lysosomal enzyme activity and autophagic perturbations, suggesting an impairment of the autophagy-lysosomal pathway in parkin-deficient cells. Interestingly, activity of the GBA-encoded enzyme, β-glucocerebrosidase, was increased, suggesting the existence of a compensatory mechanism. In conclusion, our data provide a unique characterization of the morphology, content, and function of lysosomes in PARK2 KO neurons and reveal an important new connection between mitochondrial dysfunction and lysosomal dysregulation in PD pathogenesis.

1 December 2019 in Neurobiology of Disease
Verified
Journal Article
Open access
HBHelle Bogetofte
Helle Bogetofte
PJPia Jensen
Pia Jensen
JOJustyna Okarmus
Justyna Okarmus
SSSissel Ida Schmidt
Sissel Ida Schmidt
MAMikkel Agger
Mikkel Agger
Morten MeyerMorten Meyer
Morten Meyer
Mutations in parkin, encoded by the PARK2 gene, causes early-onset familial Parkinson's disease (PD), but dysfunctional parkin has also been implicated in sporadic PD. By combining human isogenic induced pluripotent stem cells (iPSCs) with and without PARK2 knockout (KO) and a novel large-scale mass spectrometry based proteomics and post-translational modification (PTM)-omics approach, we have mapped changes in protein profiles and PTMs caused by parkin deficiency in neurons. Our study identifies changes to several proteins previously shown to be dysregulated in brains of sporadic PD patients. Pathway analysis and subsequent in vitro assays reveal perturbations in migration and neurite outgrowth in the PARK2 KO neurons. We confirm the neurite defects using long-term engraftment of neurons in the striatum of immunosuppressed hemiparkinsonian adult rats. The GTP-binding protein RhoA was identified as a key upstream regulator, and RhoA activity was significantly increased in PARK2 KO neurons. By inhibiting RhoA signalling the migration and neurite outgrowth phenotypes could be rescued. Our study provides new insight into the pathogenesis of PD and demonstrates the broadly applicable potential of proteomics and PTMomics for elucidating the role of disease-causing mutations.